GSK's OTC Nexium Commercial In UK Didn't Encourage Inappropriate Use, Ad Watchdog Says
Executive Summary
UK TV commercial for GSK's Nexium Control acid reflux treatment investigated by Advertising Standards Authority after complaint alleged promotion was irresponsible and potentially harmful. ASA found no wrongdoing by GSK and judged firm didn't breach UK Code of Broadcast Advertising.
You may also be interested in...
Haleon's UK Nexium Extension Sates Appetite For Larger Pack Size
The launch of a larger pack size for Nexium Control offers frequent heartburn sufferers “improved value at a lower cost per tablet, and a second course of medication on hand should their symptoms reoccur at a later date,” says Haleon.
GSK Consumer Split Set For July, With Emerging Markets And Switch To Drive Growth
GSK will spin-off its consumer health business in July under the name Haleon. The standalone operation expects to outpace market growth rates by expanding in emerging markets, tapping into consumer demand for more natural products and delivering two Rx-to-OTC switches in the US.
GSK And Pfizer Assemble Consumer Healthcare Leadership Team As JV Closes
Under Brian McNamara’s leadership, GSK Consumer Healthcare has begun to assemble a management team that combines talent from both GSK and Pfizer.